Concord Drugs Ltd share price logo

Concord Drugs Ltd

BSE: 538965

Small Cap

Pharma Sector

₹80.99

+0.68

(+0.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Concord Drugs Stock Performance

as on September 4, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹78.59
    ₹81.99
    downward going graph

    2.96%

    Downside

    1.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹61.00
    ₹92.52
    downward going graph

    24.68%

    Downside

    14.24%

    Upside

    downward going graph

Concord Drugs share price movements today

Previous Close
₹80.31
Open
₹81.80
Volume
1,912.00
Upper Circuit
₹96.37
Lower Circuit
₹64.25
Day's Low - High
₹78.59 - ₹81.99
52 Week Low - High
₹61.00 - ₹92.52

Concord Drugs Historical Returns

1 Month Return
+ 10.11 %
3 Month Return
+ 0.89 %
1 Year Return
+ 22.45 %
3 Year Return
+ 121.55 %
5 Year Return
+ 207.3 %

Concord Drugs Fundamentals

as on September 4, 2026 at 4:01 pm IST

Market Cap

₹106.48 Cr

Return on Equity (ROE)

0.88

PE Ratio (TTM)

48.4

Return on capital employed (ROCE)

4.49

Industry PE ratio

52.21

Beta (LTM)

0.44

P/B Ratio

0.91

Dividend Yield

0

PEG Ratio

39.03

Quarterly Earnings Growth YOY

825

EPS (TTM)

0.34

Book Value

34.11

Concord Drugs Stock Valuation

as on September 4, 2026 at 4:01 pm IST

Concord Drugs in the last 5 years

  • Overview

  • Trends

Lowest (-961.50x)

January 3, 2025

Today (48.40x)

September 4, 2026

Industry (52.21x)

September 4, 2026

Highest (791.40x)

July 3, 2024

LowHigh

Today’s Price to Earnings Ratio: 48.40x

Concord Drugs Technical Analysis

Track how Concord Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Neutral

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish5
Bullish5
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
-0.02
Bullish
CCI (20)
14.01
Neutral
RSI (14)
0.48
Bullish
Momentum (10)
0
Neutral
ADI (14)
91.34
Neutral
Ultimate Oscillator (7,14,28)
64.73
Neutral

Moving Averages

Name

Value

Action

SMA (20)
80.81
Bearish
EMA (20)
80.82
Bearish
VWMA (20)
80.8
Bearish
SMA (50)
80.86
Bearish
EMA (50)
80.84
Bearish
SMA (200)
80.31
Bullish
EMA (200)
80.64
Bullish
KAMA (200)
80.8
Neutral
DEMA (200)
80.8
Bullish

Concord Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Concord Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Concord Drugs Ltd image
Concord Drugs Ltd
NA106.4841.46%0.70145
Cian Healthcare Ltd image
Cian Healthcare Ltd
NA33.48-4.06%0.82-2630
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA120.63-12.79%0.00-2743
Aarti Drugs Ltd image
Aarti Drugs Ltd
HOLD3,939.67-6.02%0.661942,565
Concord Biotech Ltd image
Concord Biotech Ltd
BUY14,825.1610.06%0.502591,054
See all

Concord Drugs Stock’s Investor Sentiment and Interest

Search interest for Concord Drugs Ltd Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:43% versus previous 30 day period

Concord Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
7.52
12.78
15.64
11.69
12.36
10.8
10.39
13.61
10.28
16.97
37.89
20.94
Total Income
7.52
12.78
15.64
11.69
12.37
10.8
10.4
13.61
10.28
16.99
37.9
20.95
Expenses
5.91
12.15
15.29
10.86
11.49
9.41
9.35
12.59
9.18
16.05
36.4
18.66
Operating Profit
1.61
0.63
0.35
0.83
0.87
1.39
1.04
1.02
1.1
0.92
1.49
2.28
Operating Profit Margin %
21.41%
4.93%
2.24%
7.1%
7.04%
12.87%
10.01%
7.49%
10.7%
5.42%
3.93%
10.89%
Profit Before Interest, Tax and Depreciation
1.61
0.63
0.35
0.83
0.88
1.39
1.05
1.02
1.1
0.94
1.5
2.29
Interest
0.43
0.5
0.5
0.45
0.47
0.5
0.61
0.49
0.49
0.34
0.4
0.4
Depreciation
0.39
0.39
0.39
0.34
0.34
0.37
0.38
0.37
0.34
0.31
0.35
0.35
Profit Before Tax
0.79
-0.26
-0.54
0.04
0.07
0.52
0.06
0.16
0.27
0.29
0.75
1.54
Tax Paid
0.24
-0.01
-0.21
0.02
0.03
0.31
0.02
0.04
0.08
0.08
0.22
0.43
Profit After Tax
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.22
0.53
1.11
Total Net profit including share of profit / Loss from associate company
0.56
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.22
0.53
1.11
EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85
Actual EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85
Adjusted EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85
Diluted EPS
0.6
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19
0.16
0.47
0.85

Concord Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
58.96
52.08
44.92
45.24
78.74
Total Income
59.06
52.09
44.93
45.26
78.77
Expenses
53.36
47.51
40.88
41.11
74.22
Operating Profit
5.6
4.57
4.04
4.13
4.52
Operating Profit Margin %
9.5%
8.77%
8.99%
9.13%
5.74%
Profit Before Interest, Tax and Depreciation
5.69
4.58
4.05
4.15
4.55
Interest
1.68
1.71
1.87
2.03
1.71
Depreciation
1.76
1.63
1.56
1.43
1.37
Profit Before Tax
2.25
1.24
0.62
0.69
1.47
Tax Paid
0.65
0.26
0.16
0.35
0.42
Profit After Tax
1.59
0.99
0.47
0.34
1.06
Total Net profit including share of profit / Loss from associate company
1.59
0.99
0.47
0.34
1.06
EPS
1.82
1.06
0.47
0.34
0.95
Actual EPS
1.82
1.06
0.47
0.34
0.95
Adjusted EPS
1.82
1.06
0.47
0.34
0.95
Diluted EPS
1.82
1.06
0.47
0.34
0.95

Concord Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.77
1.66
0.79
3.72
Cash Flow from Investing Activities
0.01
-1.41
0.01
0.01
Cash Flow from Financing Activities
1.68
0.62
0.27
-1.43
Net Cash Flow
0.01
0.02
0.07
-0.02

Concord Drugs Stock Shareholding Pattern

Numbers in percentages

Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Nov 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
55.41%
55.41%
55.41%
55.41%
54.39%
54.39%
54.39%
54.39%
54.39%
45.08%
54.39%
54.39%
45.08%
Public
44.59%
44.59%
44.59%
44.59%
45.61%
45.61%
45.61%
45.61%
45.61%
54.92%
45.61%
45.61%
54.92%
Total Outstanding Shares
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,00,00,000
1,31,75,000
1,00,00,000
1,00,00,000
1,31,75,000
Total Shareholders
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189
4,718
4,597
4,597
4,464
4,435

Concord Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Concord Drugs.

  • Concord Drugs Ltd Earnings Results

    Concord Drugs Ltd’s net profit jumped 825% since last year same period to ₹1.11Cr in the Q1 2026-2027. On a quarterly growth basis, Concord Drugs Ltd has generated 109.43% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Concord Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.61% to 54.92% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 6 quarters, 0.04 Cr → 1.11 Cr (in ₹), with an average increase of 45.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Concord Drugs stock has moved up by 10.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 51.0% return, outperforming this stock by 28.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 152.7% return, outperforming this stock by 31.1%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 54.39% to 45.08% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 37.9 Cr → 20.95 Cr (in ₹), with an average decrease of 44.7% per quarter

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is one of the most reputable pharmaceutical companies in India that manufactures Finished Pharmaceutical Formulations such as Injectables, Small Volume Parenterals, Dry Powder, Tissue BioAdhesive Tablets, Capsules and Ophthalmic Preparations, and Readytofill Pellets. They specialize in cGMP contract manufacturing and FormulationFillFinish facility providing comprehensive pharmaceutical development and manufacturing services for drug products. Through the use of state-of-the-art technology that ensures the highest level of process integrity and product quality, they strive to provide their customers with an end-to-end solution to their various pharmaceutical product needs. In order to meet the standards set by regulatory bodies, their two manufacturing facilities are designed to comply with the prerequisites of these governing bodies.

Revenue: ₹20.94Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1.11Cr as on June 2026 (Q1 FY27)
Chairperson Name: S Nagi Reddy
OrganisationConcord Drugs Ltd
IndustryPharmaceuticals
CEOS Nagi Reddy
E-voting on sharesClick here to vote

FAQs

What is Concord Drugs share price today?

Concord Drugs share price today stands at ₹80.99 as on at the close of the market. Concord Drugs share today touched a day high of ₹81.99 and a low of ₹78.59.

What is the 52 week high and 52 week low range for Concord Drugs share?

Concord Drugs touched a 52 week high of ₹92.52 and a 52 week low of ₹61. Concord Drugs share price today i.e. is closed at ₹80.99, which is -12.46% down from its 52 week high and 32.77% up from its 52 week low.

What is Concord Drugs's market capitalisation today?

Concord Drugs market capitalisation is ₹106.48 Cr as on .

How to buy Concord Drugs shares?

To buy Concord Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 538965 or Concord Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Concord Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Concord Drugs trading volume today?

Concord Drugs trading volume is 1,912.00 as on . This means that 1,912.00 shares of Concord Drugs were bought and sold on the stock market during today's trading session.